daiichi sankyo co ltd
(4568:Tokyo Stock Exchange)
Former External Auditor, Daiichi Sankyo Company, Limited
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Mr. Kaoru Shimada served as Director of Microbiology, Tokyo Welfare Institute Hospital Since April 1972. Mr. Shimada served as Faculty of Medicine, the University of Tokyo, Department of Internal Medicine, in April 1960. Starting in August 1984, Mr. Shimada was a Professor for Infectious Diseases, Institute of Medical Science, the University of Tokyo. since April 1991, Mr. Shimada served as Director of the Research Hospital, The Institute of Medical Science, the University ...
3-5-1, Nihonbashi-honchoPhone: 81 3 6225 1111
Tokyo, -- 103-8426
Board Members Memberships*
Former External Auditor
Education*There is no Education data available.
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ron Squarer BSc (Biochemistry), MBA||Chief Executive Officer and Director|
Array BioPharma, Inc.
|Jon P. Stonehouse||Chief Executive Officer, President and Executive Director|
BioCryst Pharmaceuticals, Inc.
|Marc M.P. de Garidel||Chairman, Chief Executive Officer and Member of Strategic Committee|
|Alexandre Merieux||Chief Executive Officer, Director and Member of Strategy Committee|
|Adelene Q. Perkins||Chairman of The Board, Chief Executive Officer and President|
Infinity Pharmaceuticals, Inc.
|$568.5K||Compensation as of Fiscal Year 2014.|